ArticleLeukemia & lymphoma2016

Phase 1 trial of carfilzomib (PR-171) in combination with vorinostat (SAHA) in patients with relapsed or refractory B-cell lymphomas.

Beata Holkova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.